Watch for Tirzepatide for Sleep Apnea on Home Med Lists

April 2025

More home med lists will include tirzepatide (Zepbound).

This injectable GIP/GLP-1 agonist is the first Rx med approved for moderate to severe obstructive sleep apnea in adults with obesity.

The thought is that tirzepatide reduces weight, including the fat in the upper airway, which can lessen obstruction and improve apnea symptoms.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote